Skip to main content
. 2017 Feb 6;17:94. doi: 10.1186/s12906-017-1610-x

Fig. 6.

Fig. 6

Effects of EAF on MDA levels in T2D rats. NDC: non-diabetic control; DC: diabetic control, D + EAF25: diabetic rats treated with ethyl acetate fraction 25 mg/kg b.w.; D + EAF50: diabetic rats treated with ethyl acetate fraction 50 mg/kg b.w.; D + GLI: diabetic rats treated with glibenclamide 10 mg/kg b.w. The results are considered significant when p < 0.05. aCompared with NDC, *Compared with DC